The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060

被引:88
作者
Bagust, A [1 ]
Hopkinson, PK
Maslove, L
Currie, CJ
机构
[1] Univ York, York Hlth Econ Consortium, York YO10 5DD, N Yorkshire, England
[2] GlaxoSmithKline, Greenford, Middx, England
[3] Univ Wales Hosp, Dept Med, Cardiff CF4 4XW, S Glam, Wales
关键词
economics; epidemiology; health care costs; modelling; Type; 2; diabetes;
D O I
10.1046/j.1464-5491.19.s4.2.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis To predict the incidence and prevalence of Type 2 diabetes in the UK, the trends in the levels of diabetes-related complications, and the associated health care costs for the period 2000-60. Methods An established epidemiological and economic model of the long-term complications and health care costs of Type 2 diabetes was applied to UK population projections from 2000 to 2060. The model was used to calculate the incidence and prevalence of Type 2 diabetes, the caseloads and population burden for diabetes-related complications, and annual NHS health care costs for Type 2 diabetes over this time period. Results The total UK population will not increase by more than 3% at any time in the next 60 years. However, the population over 30 will increase by a maximum of 11% by 2030. Due to population ageing, in 2036 there will be approximately 20% more cases of Type 2 diabetes than in 2000. Cases of diabetes-related complications will increase rapidly to peak 20-30% above present levels between 2035 and 2045, before showing a modest decline. The cost of health care for patients with Type 2 diabetes rises by up to 25% during this period, but because of reductions in the economically active age groups, the relative economic burden of the disease can be expected to increase by 40-50%. Conclusion/interpretation In the next 30 years Type 2 diabetes will present a serious clinical and financial challenge to the UK NHS.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 11 条